| Literature DB >> 28666115 |
Christopher J Nirschl1, Mayte Suárez-Fariñas2, Benjamin Izar3, Sanjay Prakadan4, Ruth Dannenfelser5, Itay Tirosh6, Yong Liu1, Qian Zhu5, K Sanjana P Devi1, Shaina L Carroll4, David Chau1, Melika Rezaee7, Tae-Gyun Kim1, Ruiqi Huang8, Judilyn Fuentes-Duculan9, George X Song-Zhao1, Nicholas Gulati9, Michelle A Lowes9, Sandra L King1, Francisco J Quintana10, Young-Suk Lee5, James G Krueger9, Kavita Y Sarin7, Charles H Yoon11, Levi Garraway12, Aviv Regev13, Alex K Shalek14, Olga Troyanskaya15, Niroshana Anandasabapathy16.
Abstract
Homeostatic programs balance immune protection and self-tolerance. Such mechanisms likely impact autoimmunity and tumor formation, respectively. How homeostasis is maintained and impacts tumor surveillance is unknown. Here, we find that different immune mononuclear phagocytes share a conserved steady-state program during differentiation and entry into healthy tissue. IFNγ is necessary and sufficient to induce this program, revealing a key instructive role. Remarkably, homeostatic and IFNγ-dependent programs enrich across primary human tumors, including melanoma, and stratify survival. Single-cell RNA sequencing (RNA-seq) reveals enrichment of homeostatic modules in monocytes and DCs from human metastatic melanoma. Suppressor-of-cytokine-2 (SOCS2) protein, a conserved program transcript, is expressed by mononuclear phagocytes infiltrating primary melanoma and is induced by IFNγ. SOCS2 limits adaptive anti-tumoral immunity and DC-based priming of T cells in vivo, indicating a critical regulatory role. These findings link immune homeostasis to key determinants of anti-tumoral immunity and escape, revealing co-opting of tissue-specific immune development in the tumor microenvironment.Entities:
Keywords: IFNγ; dendritic cells; differentiation; homeostasis; immunotherapy; melanoma; suppressor-of-cytokine-signaling 2 (SOCS2); tissue mononuclear phagocytes; tolerance; tumor microenvironment
Mesh:
Substances:
Year: 2017 PMID: 28666115 PMCID: PMC5569303 DOI: 10.1016/j.cell.2017.06.016
Source DB: PubMed Journal: Cell ISSN: 0092-8674 Impact factor: 41.582